However, the average educational level was high in this study thus, caution should be exercised when extrapolating these results to individuals with lower educational levels. The MoCA‐S is valid and adequate for application in Colombia with good internal consistency, inter‐observer reliability, and content validity. The MoCA‐S is a valid screening tool and is useful for identifying MCI and MD in Colombia. The percentage of patients clearly labeled by the MoCA‐S was 85%. Using a cutoff score of ≥23, the MoCA had sensitivities of 76.0% to detect MCI and 92.7% to detect MD and a specificity of 79.8%. The psychometric evaluation of the MoCA‐S was appropriate. The remaining 84 participants were healthy subjects from the community. A total of 193 subjects were evaluated, 109 of whom were patients, including 26 who met the mild cognitive impairment (MCI) clinical criteria, based on neuropsychological testing, and 83 who had mild dementia (MD). This study is the first validation in Latin America of the MoCA in Spanish (MoCA‐S), which was developed in Colombia (South America).Īiming to perform the first validation of the MoCA‐S, we developed a study of concordance by conformity to assess the MoCA‐S compared with diagnostic consensus by interdisciplinary assessment in the Memory Clinic (the best diagnostic method available) and to evaluate the psychometric properties of the MoCA‐S. The Montreal Cognitive Assessment (MoCA) was developed as a simple screening tool for cognitive impairment.

Validation of the Montreal Cognitive Assessment (MoCA) in Spanish as a screening tool for mild cognitive impairment and mild dementia in patients over 65 years old in Bogotá, Colombia International Journal of Geriatric Psychiatry Vol. MoCAalso known as Montreal Cognitive Assessment or The MoCA Testwas validated as a highly sensitive tool for early detection of mild cognitive impairment (MCI) in 2000.

Moca test pdf spanish